Study: Just Half of Postmarketing Commitment Trials are Published

A new study published Monday in BMC Medicine finds that only about half of the clinical trials requested by the US Food and Drug Administration (FDA) as part of postmarketing commitments for newly approved drugs and biologics are published in peer-reviewed journals.